DHA sbir PH II H2S-0039 (months 1-23)
Ended Definitive Contract Awarded Last action
- Contract number
- HT942523C0050
- Awardee
-
Daxor Corporation UEI QGB8LQAGTAH8 Part of Daxor Corporation
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,649,997
Award facts
- Opportunity
-
- HQ003419ROCAB Solicitation number
- Contract value 100% obligated
- $1,649,996.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Oak Ridge, TN 37830, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $550,000 | |
| Original award | $1,099,997 |
About this award
This is a $1,649,996.73 Firm Fixed Price Definitive Contract awarded by the Defense Health Agency (DHA) to Daxor Corporation, a self-certified small disadvantaged business, for a SBIR Phase II project titled "Direct Blood Volume Analyzer for Improvement of Combat Casualty Care". The contract has a period of performance from July 3, 2023 to November 2, 2025 and is a total small business set-aside. Daxor Corporation, based in Oak Ridge, Tennessee, specializes in medical instrumentation and diagnostic technologies, with a focus on blood volume analysis and medical research. This SBIR Phase II contract continues the company's work on developing advanced diagnostic tools and technologies to improve combat casualty care, building on prior SBIR Phase I research. The goal is to create innovative blood volume analysis capabilities that can enhance medical interventions and treatment strategies in military medical settings.
Quick answers
Who was awarded contract HT942523C0050?
HT942523C0050 was awarded to Daxor Corporation by Defense Health Agency (Department of Defense) on July 3, 2023.
How much is contract HT942523C0050 worth?
The government has obligated $1,649,997 on HT942523C0050.
Was contract HT942523C0050 competed?
The extent of competition for HT942523C0050 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award